Industry News & Updates

WELCOME TO QUADRA’S PHARMACEUTICAL INDUSTRY NEWS & UPDATES SECTION! FOLLOW TRENDS, CHECK OUT NEW PRODUCTS, AND READ ARTICLES & FEATURES RELEVANT TO THIS SECTOR. CHECK BACK OFTEN AS THIS PAGE UPDATES FREQUENTLY!

Webinar Series – HPC Advantages compared to HPMC for Sustained Release Matrix Tablets – with Nisso HPC

Posted on

Connect & Learn with Quadra Ingredients

Welcome to Quadra Ingredients Fall Webinar Series

Our 5th session in our new webinar series will be held on Wednesday October 21st @ 2 pm EST.  We will be featuring Nisso HPC, our supply partner for the Canadian Pharma and Supplement markets and the US  Pharma markets.

Join us as Dr. Edmont Stoyanov presents  – HPC advantages compared to HPMC for Sustained Release Matrix Tablets

Nisso HPC (hydroxypropyl cellulose) is available in high-molecular weight, fine powder grades designed for direct compression sustained release tablets.  These hydrophilic matrix tablets can be formulated to control drug release from 4 to 24 hours.

Compared to HPMC, tablets made with HPC are:

  • easier to manufacture with lower compression force
  • more robust and less variable in-vitro and in-vivo
  • Non-GMO Project Verified for customer friendliness
  • This webinar will present case studies and formulation recommendations

Please feel free to share this invite with your colleagues that you think may have interest.

We’re looking forward to connecting and learning with you online.

Click Here to Register